05:42 PM EDT, 10/16/2025 (MT Newswires) -- CVS Health ( CVS ) said Thursday its specialty pharmacy will serve as a core partner in the TrumpRx Fertility program, a federal initiative aimed at expanding access to lower-cost fertility treatments.

The company said it will work with EMD Serono, manufacturer of the in-vitro fertilization drug Gonal-F, which will be offered at an 84% lower price through the program.

"Fertility medications often require special administration and high-touch expertise," said Lucille Accetta, senior vice president and chief pharmacy officer at CVS Health ( CVS ).

The TrumpRx Fertility program is expected to launch in January.